Clinical Trial: Fosfomycin Plus Imipenem for Treatment of Infective Endocarditis
Study Status: Recruiting
Recruit Status: Unknown status
Study Type: Interventional
Official Title: Evaluation of the Efficacy and Safety of Fosfomycin Plus Imipenem for the Treatment of Methicillin-resistant Staphylococcus Aureus (MRSA) Infective Endocarditis.
Brief Summary: The study evaluates the efficacy and safety of fosfomycin and imipenem for the treatment of methicillin-resistant staphyloccocus aureus infective endocarditis in comparison to vancomycin, the standard therapy.
Detailed Summary:
Sponsor: Juan A. Arnaiz
Current Primary Outcome: Proportion of patients with negative blood cultures. [ Time Frame: 7 days ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Toxicity due to treatment [ Time Frame: 20 weeks ]
Original Secondary Outcome: Same as current
Information By: Hospital Clinic of Barcelona
Dates:
Date Received: March 27, 2009
Date Started: July 2009
Date Completion: December 2013
Last Updated: February 21, 2013
Last Verified: February 2013